Related Experiment Video
Updated: Mar 13, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Overcoming Diagnostic and Therapeutic Challenges in Primary Cardiac Angiosarcoma
Alexandra Pons-Riverola1, Andrea Napolitano2, Ulrich Rosendahl3
1Cardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom.
Insights
Diagnosing rare cardiac tumors can be difficult when tissue samples are unobtainable. This case highlights the importance of multimodality imaging and personalized treatment for aggressive cardiac angiosarcoma.
Area of Science:
- Cardiology
- Oncology
- Radiology
Background:
- Multimodality imaging is vital for cardiac mass evaluation.
- Histopathology is the gold standard for diagnosis, but challenging in rare cases.
- Obtaining tissue samples can be difficult or impossible in certain cardiac tumors.
Background:
Multimodality imaging plays a key role in the evaluation of cardiac masses, although histopathology remains the gold standard for definitive diagnosis. In rare cases, obtaining tissue can be challenging or even impossible.
Case Summary:
We present a patient with a highly vascularized intra- and extracardiac mass, raising strong suspicion for cardiac angiosarcoma. The case was challenging given significant hemorrhagic risk associated with the tumor's extensive vascularization, which limited the options for obtaining tissue diagnosis. Chemotherapy was started based on imaging characteristics.
Discussion:
Cardiac tumors with lack of tissue diagnosis and anatomical considerations pose significant challenges. This case demonstrates the need for personalized decision-making in rare and aggressive malignancies where standard diagnostic pathways may not be feasible.
Take-Home Messages:
Multimodality imaging has a crucial role in the assessment of cardiac tumors. Tissue diagnosis is usually feasible, but in selected cases it can be challenging or not possible.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Treatment Resistant Cancers
Cardiomyopathy II: Dilated Cardiomyopathy
